- Home
- SLNG vs CHRS Comparison
SLNG vs CHRS Comparison
Compare SLNG & CHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNG
- CHRS
- Stock Information
- Founded
- SLNG 2013
- CHRS 2010
- Country
- SLNG United States
- CHRS United States
- Employees
- SLNG N/A
- CHRS N/A
- Industry
- SLNG Oil/Gas Transmission
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SLNG Utilities
- CHRS Health Care
- Exchange
- SLNG Nasdaq
- CHRS Nasdaq
- Market Cap
- SLNG 96.5M
- CHRS 94.0M
- IPO Year
- SLNG N/A
- CHRS 2014
- Fundamental
- Price
- SLNG $4.75
- CHRS $0.82
- Analyst Decision
- SLNG Strong Buy
- CHRS Strong Buy
- Analyst Count
- SLNG 1
- CHRS 4
- Target Price
- SLNG $12.00
- CHRS $5.38
- AVG Volume (30 Days)
- SLNG 15.7K
- CHRS 2.1M
- Earning Date
- SLNG 05-06-2025
- CHRS 05-08-2025
- Dividend Yield
- SLNG N/A
- CHRS N/A
- EPS Growth
- SLNG 3561.99
- CHRS N/A
- EPS
- SLNG 0.25
- CHRS 0.25
- Revenue
- SLNG $73,293,000.00
- CHRS $266,959,999.00
- Revenue This Year
- SLNG $8.97
- CHRS N/A
- Revenue Next Year
- SLNG $6.90
- CHRS $9.02
- P/E Ratio
- SLNG $19.40
- CHRS $3.28
- Revenue Growth
- SLNG 0.24
- CHRS 3.78
- 52 Week Low
- SLNG $3.77
- CHRS $0.66
- 52 Week High
- SLNG $8.28
- CHRS $2.61
- Technical
- Relative Strength Index (RSI)
- SLNG 37.26
- CHRS 38.64
- Support Level
- SLNG $4.63
- CHRS $0.79
- Resistance Level
- SLNG $5.18
- CHRS $0.92
- Average True Range (ATR)
- SLNG 0.28
- CHRS 0.08
- MACD
- SLNG 0.03
- CHRS -0.00
- Stochastic Oscillator
- SLNG 15.79
- CHRS 11.32
About SLNG Stabilis Solutions Inc.
Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.
About CHRS Coherus BioSciences Inc.
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative immunotherapies to treat cancer. Coherus is developing an innovative immuno-oncology pipeline which includes multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable a robust antitumor immunologic response and enhance outcomes for patients with cancer.